{
  "id": "CD015003.PUB2",
  "draft": "Can colchicine (an anti-inflammatory medicine) help prevent heart attacks, strokes, and other cardiovascular events in people who have not had any of these problems before?\n\nKey Messages\n- Colchicine may help reduce the risk of death from any cause in people who have not had any heart or blood vessel problems before, but the evidence is not strong enough to be certain. It may also increase the risk of diarrhoea.\n- The current evidence does not clearly show whether colchicine can prevent heart attacks, strokes, or other cardiovascular events in people without a history of these problems, highlighting the need for more research to understand its effects.\n- Future studies should investigate the long-term effects of colchicine and its potential benefits and harms in preventing cardiovascular events, as the current evidence is limited by biases and inaccuracies in the included studies, making it difficult to draw firm conclusions.\n\nWhat is atherosclerotic cardiovascular disease and why is it a problem?\nAtherosclerotic cardiovascular disease (ACVD) is when fatty substances clog the arteries. This can cause long-lasting inflammation and serious, even life-threatening, health problems. It is a major cause of mortality and morbidity worldwide, resulting in significant healthcare burdens and impacting the quality of life for millions of people. Common treatments for ACVD often focus on managing symptoms and reducing risk factors, but there is a need for effective preventive measures.\n\nWhat is colchicine and how might it help with ACVD prevention?\nColchicine is an inexpensive drug with anti-inflammatory properties that has been used for centuries. Its potential role in preventing ACVD is of interest due to its ability to reduce inflammation, a key factor in the development of the disease. However, the effectiveness of colchicine in preventing cardiovascular events in the general population remains unknown, highlighting the need for rigorous research to determine its clinical benefits and harms.\n\nWhat did the review authors want to find out?\nThe review authors aimed to assess the clinical benefits and harms of using colchicine for the primary prevention of cardiovascular events in the general population. They compared colchicine to placebo, immunomodulating medications, or usual care to determine its effectiveness in reducing the risk of cardiovascular outcomes such as all-cause mortality, non-fatal heart attacks, stroke, and adverse events.\n\nHow did we find the evidence?\nWe searched for studies comparing colchicine to other treatments for preventing cardiovascular events, summarized their results, and rated our confidence in the evidence.\n\nWhat did we find?\nWe found 15 studies. Researchers randomly assigned 1721 people to groups, and we analyzed data from 1412 participants. The studies were conducted with follow-up periods ranging from 4 to 728 weeks. The intervention was oral colchicine compared with placebo, immunomodulating drugs, or usual care or no treatment. Most of the included trials focused on liver disease, rather than the general population. Colchicine may reduce the risk of all-cause mortality, but we are very uncertain about the results. It may make little to no difference to the risk of non-fatal heart attacks, but we are very uncertain about the results. Colchicine may increase the risk of diarrhoea. For every 100 people taking colchicine, 10 may experience diarrhoea, compared to 3 of 100 people not taking colchicine.\n\nWhat are the limitations of this evidence?\nThe evidence is limited because the studies were very small, participants may have been aware of their assigned treatment (risk of bias due to lack of blinding), and the evidence does not cover all relevant populations, interventions, comparators, or outcomes of interest.\n\nHow up to date is this evidence?\nThe evidence is up to date to May 2023.",
  "metrics": [
    {
      "linguistic_evaluation": {
        "words": {
          "value": 624,
          "rating": "within_limit",
          "direction": null,
          "feedback": null
        },
        "sentences": {
          "value": 32,
          "rating": "info",
          "direction": null,
          "feedback": null
        },
        "words_per_sentence": {
          "value": 19.5,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "passive_voice": {
          "value": 15,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "active_voice": {
          "value": 54,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "pronouns": {
          "value": 34,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "nominalization": {
          "value": 24,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 24.0 to <13.0 (median)"
        },
        "nouns": {
          "value": 164,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 164.0 to <116.0 (median)"
        },
        "flesch_reading_ease": {
          "value": 44.28000000000003,
          "rating": "P50",
          "direction": "higher_better",
          "feedback": null
        },
        "flesch_kincaid_grade": {
          "value": 11.927500000000002,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "automated_readability_index": {
          "value": 12.171923076923072,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "coleman_liau_index": {
          "value": 12.45897435897436,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "gunning_fog_index": {
          "value": 17.030769230769234,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "lix": {
          "value": 51.391025641025635,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "rix": {
          "value": 6.21875,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "smog_index": {
          "value": 14.704699910719626,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 14.7 to <12.1 (median)"
        },
        "dale_chall_readability": {
          "value": 7.116190384615385,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "complex_words_dc": {
          "value": 243,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 243.0 to <160.0 (median)"
        },
        "complex_words": {
          "value": 144,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 144.0 to <84.0 (median)"
        },
        "long_words": {
          "value": 199,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 199.0 to <122.0 (median)"
        }
      },
      "word_count_status": {
        "word_count": 624,
        "limit": 850,
        "status": "within_limit",
        "message": "Word count: 624 ✓ WITHIN LIMIT (≤850 words)"
      },
      "summary": {
        "P25_count": 2,
        "P50_count": 7,
        "P75_count": 3,
        "P90_count": 6,
        "P10_count": 0,
        "BEYOND_P90_count": 0,
        "BELOW_P10_count": 0,
        "total_evaluated": 18,
        "P25_percentage": 11.11111111111111,
        "P50_percentage": 38.88888888888889,
        "P75_percentage": 16.666666666666664,
        "P90_percentage": 33.33333333333333,
        "P10_percentage": 0,
        "BEYOND_P90_percentage": 0,
        "BELOW_P10_percentage": 0,
        "best_quartile_rate": 27.77777777777778,
        "overall_assessment": "MODERATE CONFORMITY WITH PLS PATTERNS"
      }
    }
  ],
  "evaluation": [
    {
      "grade": "NOT_APPROVED",
      "feedback": "This is a solid draft that is factually accurate, complete, and well-structured. However, the language is often too academic and complex for a general audience, which could prevent readers from fully understanding the key messages. To improve clarity, I recommend focusing on simplifying sentence structure and replacing technical terms with everyday language.\n\nHere are the top 3 improvements I suggest:\n\n1.  **Replace abstract nouns with simpler, more direct phrases.** The text uses many noun forms where verbs would be clearer. This is supported by the high 'nominalization' score.\n    *   **Original:** \"It is a major cause of mortality and morbidity worldwide, resulting in significant healthcare burdens and impacting the quality of life for millions of people.\"\n    *   **Problem:** Words like 'mortality', 'morbidity', and 'healthcare burdens' are technical and abstract. \n    *   **Suggestion:** \"This disease is a leading cause of death and disability around the world. It puts a strain on healthcare systems and affects the quality of life for millions of people.\"\n\n2.  **Simplify wordy and academic phrasing.** Some sentences can be made more direct and easier to follow.\n    *   **Original:** \"However, the effectiveness of colchicine in preventing cardiovascular events in the general population remains unknown, highlighting the need for rigorous research to determine its clinical benefits and harms.\"\n    *   **Problem:** This sentence is long and uses complex phrasing like 'effectiveness remains unknown' and 'highlighting the need for'.\n    *   **Suggestion:** \"However, we still don't know if colchicine can prevent these heart and blood vessel problems for most people. We need more and better research to find out its true benefits and harms.\"\n\n3.  **Use active voice to make it clear who is doing what.** The style guide recommends active voice, and some sentences use passive constructions that can be confusing.\n    *   **Original:** \"The intervention was oral colchicine compared with placebo, immunomodulating drugs, or usual care or no treatment.\"\n    *   **Problem:** This is written in a passive style (\"The intervention was...\").\n    *   **Suggestion:** \"In the studies, researchers compared people taking colchicine by mouth to people taking a placebo (a dummy pill), other anti-inflammatory drugs, or having usual care.\",",
      "pls_evaluation_summary": "The linguistic analysis shows MODERATE CONFORMITY with typical PLS patterns. While sentence length and pronoun use are good (P25 and P75 respectively), the draft deviates significantly in vocabulary complexity. Six key metrics are in the P90 range, indicating the text is much more complex than a typical PLS. These include 'nominalization' (noun-form verbs), 'nouns', 'smog_index' (readability), 'complex_words_dc' (unfamiliar words), 'complex_words' (3+ syllables), and 'long_words' (7+ characters). This suggests the main area for improvement is simplifying vocabulary and sentence structure to enhance readability for a lay audience."
    }
  ]
}